During the past decade, The Fe/Male Health Centres conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Fe/Male Health Centres" #1 sponsor was "CMX Research" with 6 trials, followed by "AEterna Zentaris" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "Bioniche Life Sciences Inc." with 1 trials sponsored and "Lidds AB" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Fe/Male Health Centres" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "CMX Research" with 1 trials as a collaborator, "Ferring Pharmaceuticals" with 1 trials as a collaborator, "Peptigroupe Inc." with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "The Fe/Male Health Centres" are "Prostate Cancer" (4 trials), "Benign Prostatic Hypertrophy" (2 trials), "Nocturia" (2 trials), "Urinary Incontinence" (2 trials) and "Benign Prostatic Hyperplasia" (1 trials). Many other conditions were trialed in "The Fe/Male Health Centres" in a lesser frequency.

Most popular intervention types in "The Fe/Male Health Centres" are "Drug" (8 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "2-Hydroxyflutamide Depot" (1 trials), "Cetrorelix 78 mg + 52 mg" (1 trials), "Cetrorelix 78 mg + 78 mg" (1 trials) and "Cetrorelix Pamoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Fe/Male Health Centres" are 10 trials for "Male" genders, 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Fe/Male Health Centres". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in The Fe/Male Health Centres, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Fe/Male Health Centres, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".